In view of the methodological problems of epidemiological studies on a
ssociations between exposures to 50/60 Hz magnetic fields (MF) and inc
reased incidence of cancers, laboratory studies are necessary to deter
mine if 50/60 Hz MF are cancer promoters or can progress cancers. The
objective of the present study was to determine if an alternating MF o
f low flux density exerts tumor-promoting or co-promoting effects in a
model of breast cancer in female rats. Mammary tumors were induced by
the chemical carcinogen 7,12-dimethylbenz(a)anthracene (DMBA). A grou
p of 99 rats was exposed to a homogeneous MF of 50 Hz, 100 muT (microt
esla), for 24 h/day 7 day/week for a period of 91 days, another group
of 99 rats was sham-exposed under the same environmental conditions as
the MF-exposed rats. The exposure chambers were identical for MF-expo
sed and sham-exposed animals, DMBA was administered orally at a dose o
f 5 mg/kg at the first day of exposure and at weekly intervals thereaf
ter up to a total dose of 20 mg per rat. The animals were palpated onc
e weekly to assess the development of mammary tumors. In controls, DMB
A induced tumors in about 40% of the animals within three months of fi
rst application. Eight weeks after DMBA application the MF-exposed rat
s exhibited significantly more tumors than sham-exposed animals. This
difference in the rate of tumor development was observed throughout th
e period of exposure. At the end of the three-month period of MF expos
ure the tumor incidence in MF-exposed rats was 50% higher than in sham
-exposed rats, the difference being statistically significant. Further
more, the size of tumors as estimated by palpation was significantly l
arger in the MF-exposed compared to sham-exposed rats. The data demons
trates that long-term exposure of DMBA-treated female rats to an alter
nating MF of low flux density promotes the growth and increases the in
cidence of mammary tumors, thus strongly indicating that MF exposure e
xerts tumor-promoting and/or copromoting effects.